This presentation will focus on the evidence in our literature on the use of urodynamic testing. We will focus on the strengths and limitations of urodynamics as a diagnostic test and as a prognostic test. We will also review the evidence on when an office stress test or prolapse reduction stress test can replace urodynamics in the evaluation of stress incontinence or prolapse.

1. Understand the different components of bladder function testing
2. Understand what we can learn from this testing
3. Understand the strengths and limitations of urodynamics
4. Understand when office evaluation can replace urodynamics

Charles W. Nager, MD has served as FPMRS division director, fellowship program director and department chair at UC San Diego. In 2014, he served as president of the American Urogynecologic Society. His research focus has been on urodynamics and clinical trials in pelvic floor disorders in both the NIH Urinary Incontinence Treatment Network and the Pelvic Floor Disorders Network. He has been selected by his peers as one of San Diego’s Best Doctors for 14 consecutive years.